Trial NCT05033847
Publication Al Kaabi N, Sig Transduct Target, 2022
Dates: 2021-09-12 to 2021-11-8
Funding: Private (Presence of employees of drug/device manufacturers among the co-authors ; The inactivated vaccine BBIBP-CorV, used as a control in this trial, was provide by Beijing Institute of Biological Products Co., Ltd.)
Conflict of interest: Yes